Reduced Lordosis and Enhanced Aggression in Paced and Non-Paced Mating in Diabetic Female Rats

J Sex Med. 2018 Feb;15(2):124-135. doi: 10.1016/j.jsxm.2017.11.018. Epub 2017 Dec 21.

Abstract

Background: Clinical studies have shown altered sexual function in people with diabetes; basic science studies, using the streptozotocin (STZ)-induced animal model of type 1 diabetes mellitus (DM1), have consistently reported decreased sexual behavior in hyperglycemic female animals, but features of sexual motivation and aggressive behavior have not been explored in these animals.

Aim: To study several parameters that denote sexual motivation in STZ-treated female rats and to compare behavioral features of sexual behavior and aggression in non-paced mating (NPM) and paced mating (PM) conditions.

Methods: DM1 was induced by injecting STZ (diluted in citrate buffer) at a dose of 50 mg/kg intraperitoneally over 2 consecutive days into ovariectomized Wistar rats. 10 days later, female rats were treated with estradiol benzoate (10 μg, -24 hours) and progesterone (3 mg, -4 hours); their sexual behavior (including lordosis quotient, lordosis intensity, and proceptivity) and aggression were evaluated under NPM and PM conditions. Body weight, blood glucose levels, and spontaneous ambulatory activity also were measured. A group of STZ-treated animals was administered a long-acting insulin analogue (glargine) every 12 hours for 8 days, and their sexual and aggressive behaviors were evaluated in NPM.

Outcomes: We quantified body weight, blood glucose level, spontaneous ambulatory activity, and sexual and aggressive behaviors in NPM and PM; the time the female rats spent interacting with the male rat or in the male rat's chamber also was registered in PM.

Results: Compared with controls, STZ-treated ovariectomized rats lost body weight, had increased blood glucose levels, and had unchanged spontaneous ambulatory activity. In the PM and NPM conditions, animals showed decreased lordosis quotient and lordosis intensity, increased aggression, and unaltered proceptivity, although in NPM the effects of STZ treatment on aggression were more drastic and were completely prevented by insulin. In PM no differences were found between diabetic and control female rats in the time interacting with the male rat or in the male rat's chamber.

Clinical translation: These findings support the observation of increased prevalence of sexual dysfunctions and aggression in the clinical setting of DM1.

Strengths and limitations: The main strength of this study is that it analyzed sexual behavior under PM and NPM conditions and aggression in STZ-treated female rats. Its main limitations are that the model of DM1 represents only 10% of the affected population and that no specific treatment is proposed for the sexual dysfunctions.

Conclusion: These results suggest that STZ-treated rats have decreased sexual receptivity in NPM and PM, accompanied by increased aggressiveness in NPM. Hernández-Munive AK, Rebolledo-Solleiro D, Ventura-Aquino E, Fernández-Guasti A. Reduced Lordosis and Enhanced Aggression in Paced and Non-Paced Mating in Diabetic Female Rats. J Sex Med 2018;15:124-135.

Keywords: Aggression; Female Rats; Non-Paced Mating; Paced Mating; Sexual Dysfunction; Streptozotocin-Induced Diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aggression / drug effects*
  • Animals
  • Diabetes Mellitus, Experimental / complications
  • Estradiol / analogs & derivatives
  • Estradiol / pharmacology
  • Female
  • Lordosis / prevention & control*
  • Male
  • Motivation
  • Progesterone / pharmacology
  • Rats
  • Rats, Wistar
  • Sexual Behavior / drug effects*
  • Sexual Behavior, Animal / drug effects*
  • Streptozocin

Substances

  • estradiol 3-benzoate
  • Progesterone
  • Estradiol
  • Streptozocin